Scitara
PrivateLast Round
Seed Round
Apr 24, 2026
Total Funding Raised
$35M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Scitara operates in Healthcare & Life Sciences and is based in Marlborough, Massachusetts. Its latest recorded funding round was a Series B Extension round in October 2023.
Scitara is a SaaS and HealthTech company that provides a laboratory-specific, cloud-based software platform designed to offer a standardized platform for communication and automated workflows.
Sector
Healthcare & Life Sciences
Verticals
Data Integration, Platform-as-a-Service, Workflow Automation, Biotechnology, Compliance
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Usage-Based SaaS
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Scitara Comparables
Compare Scitara with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TetraScience | 86% | |
| Scispot | 82% | |
| Sapio Sciences | 81% |
For institutional investors. Book with your work email.
Scitara Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Apr 24, 2026 | ||||
| Series B Extension | Oct 23, 2023 | ||||
| Series B | Jan 11, 2022 | ||||
| Series A | Jan 27, 2021 | ||||
| Early Funding | Sep 11, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Scitara Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Flybridge | Series A, Series B |
| Northpond Ventures | Series B Extension, Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased to 45, representing 49% of headcount.
- Jun 21, 2026
Monthly visitors grew 300% MoM, reaching 9.4K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- attends_eventSep 21, 2026
Scitara Corporation plans to present Scitara's expanded strategy to customers and partners at the Scitara Connect event in Amsterdam, the Netherlands, in Sep '26.
- hiresSep 21, 2026
Scitara Corporation appoints Mike Tarselli, Ph.D., MBA, as Chief Strategy Officer on Sep 21st '26 to lead its expansion into AI-enabled lab intelligence, automation and agentic scientific workflows.
For institutional investors. Book with your work email.
Scitara Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Scitara's valuation, stock price, and market status.
Is Scitara a public or private company?
Scitara is a private company.
What is the current stock price of Scitara?
Scitara is a private company, so its shares have no public market price. Caplight tracks Scitara's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Scitara worth (valuation)?
Valuation information for Scitara is not publicly available.
Can I buy Scitara stock?
Scitara shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Scitara's last funding round?
Scitara's most recent funding round was Seed Round on April 24, 2026.
Who are the main investors in Scitara?
Key investors in Scitara include Northpond Ventures.
Will Scitara IPO soon?
No public IPO plans have been announced for Scitara.
How can I track Scitara secondary market activity?
Caplight tracks bids, offers, and trades in Scitara's shares on secondary markets.